Nvelop Therapeutics Announces Members of Its Scientific Advisory Board [Yahoo! Finance]
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Yahoo! Finance
CAMBRIDGE, Mass., May 02, 2024 BUSINESS WIRE Nvelop Therapeutics , a biotechnology company engineering programmable, non-viral vehicles for the in vivo delivery of therapeutic cargo, today announced the members of its scientific advisory board, bringing together a world-class group of experts from across the fields of gene therapy, gene editing and drug delivery. "It's a privilege to have this distinguished group of visionary leaders join our scientific advisory board as we work to advance two potentially breakthrough platforms for the delivery of genetic medicines, and develop our own pipeline of new treatments," said Melissa Bonner, Nvelop's chief scientific officer. "The board's collective expertise and experience will be invaluable in our efforts to develop in vivo genetic medicines for a wide range of diseases." Inaugural members of the scientific advisory board include: Aravind Asokan, Ph.D. : Dr. Asokan is a professor and director of gene therapy at Duke University, with
Show less
Read more
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- XWELL, Inc. Reports First Quarter 2024 Results [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) had its price target lowered by analysts at Morgan Stanley from $2.00 to $1.00. They now have an "equal weight" rating on the stock.MarketBeat
- What's the Difference Between Biotech Stocks and TechBio Stocks? [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) was downgraded by analysts at BTIG Research from a "neutral" rating to a "sell" rating.MarketBeat
- Ginkgo Bioworks to Participate in Two Conferences in May [Yahoo! Finance]Yahoo! Finance
DNA
Earnings
- 5/9/24 - In-Line
DNA
Sec Filings
- 5/17/24 - Form 424B3
- 5/17/24 - Form 144
- 5/16/24 - Form 144
- DNA's page on the SEC website